GSTO2 and seminoma: As far as GSTO2rs2297235 polymorphism is concerned, we found that the carriers of the GSTO2*A/G*G/G genotype exhibited increased risk for testicular GCT and seminoma development, as opposed to those with the GSTO2*AA genotype.